Vimarsana
Biggest News Aggregation in the World

Page 23 - Mckesson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mckesson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mckesson Today - Breaking & Trending Today

Citigroup Increases McKesson (NYSE:MCK) Price Target to $620.00 - Vimarsana News

Citigroup Increases McKesson (NYSE:MCK) Price Target to $620.00

McKesson (NYSE:MCK – Get Free Report) had its price target lifted by investment analysts at Citigroup from $575.00 to $620.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target points to a potential upside of 16.71% from the stock’s previous close. […]

3 Stocks to Watch in the Drug Distribution Industry - Vimarsana News

3 Stocks to Watch in the Drug Distribution Industry

These main players dominate the US drug supply chain.

To stop fentanyl deaths in Philadelphia, knocking on doors and handing out overdose kits - Vimarsana News

To stop fentanyl deaths in Philadelphia, knocking on doors and handing out overdose kits

A canvassing initiative aims to take prevention supplies directly to people who might not otherwise seek it out themselves.

Expert Discusses Payment Models for Cell and Gene Therapies - Vimarsana News

Expert Discusses Payment Models for Cell and Gene Therapies

Joe DePinto discusses innovative payment models like value-based agreements and warranties for cell and gene therapies

Financing of Curative Cell, Gene Therapies and Variability With Product Launches - Vimarsana News

Financing of Curative Cell, Gene Therapies and Variability With Product Launches

While the novel payment models for expensive cell and gene therapies have been effective, they need to continue evolving, said Joe DePinto, MBA, of McKesson.

Source: ajmc.com